Trademark Search in Canada

BAQSIMI

View On IC.GC.CA

REGISTERED

on 2 Aug 2019

Last Applicant/ Owned by

AMPHASTAR PHARMACEUTICALS INC.

11570 Sixth StreetRancho Cucamonga, CA 91730

Serial Number

1771817 filed on 10^th Mar 2016

Registration Number

TMA1046545 registered on 2^th Aug 2019

Registration expiry Date

2^th Aug 2029

Correspondent Address

CASSELS BROCK & BLACKWELL LLP

Suite 3200, Bay Adelaide Centre - North Tower40 Temperance St.Toronto,

ONTARIO

M5H0B4

BAQSIMI

Trademark usage description

pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reacti Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction.

Classification kind code

Mark Details

Serial Number

1771817

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 29^th Mar 2018	Allowed
Submitted for opposition 42 on 13^th Dec 2017	Advertised
Submitted for opposition 26 on 23^rd Nov 2017	Approved
Submitted for opposition 27 on 6^th Oct 2017	Approval Notice Sent
Submitted for opposition 12 on 3^rd Feb 2017	Extension of Time
Submitted for opposition 22 on 10^th Aug 2016	Search Recorded
Submitted for opposition 20 on 10^th Aug 2016	Examiner's First Report
Submitted for opposition 31 on 15^th Mar 2016	Formalized
Submitted for opposition 1 on 11^th Mar 2016	Created
Submitted for opposition 30 on 10^th Mar 2016	Filed

BAQSIMI

Classification Information

Class [005]Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction.